ArchiMed MED I Fund

https://www.archimed.group

Founded by Denis Ribon, previously Global Head of Healthcare at 3i, and his fellow Managing Partners, Vincent Guillaumot – another former 3i healthcare executive – and Robin Filmer-Wilson, a former 3i healthcare co-investor, ArchiMed is an independent private equity team 100% dedicated to the healthcare sector in Europe. The Managing Partners are currently investing from the €150 million Med 1 fund. The ArchiMed team also includes Operating Partner Loïc Kubitza, previously a Leader at PwC’s Healthcare and Life Sciences Practice, and Operating Partner Christoph Böhmer, formerly a McKinsey partner and Managing Director of €1 billion-in-revenues cardiovascular leader Biotronik. ArchiMed invests in all healthcare sectors, targeting profitable, established European healthcare companies and investing between €5 million and €30 million per transaction. ArchiMed engages in both unleveraged growth investments and leveraged buyouts. In the last sixteen years, the ArchiMed team has invested more than €1 billion in 20-plus companies, achieving a total return of over 2.6 times invested capital. *

	Start	2014-01-01 fund closing
	Group	ArchiMed (Group)
	Successor	ArchiMed MED II Fund
	Industry	ArchiMed MED I Fund
	Industry 2	healthcare

	Region	Lyon
	Country	France
	City	69003 Lyon
	Tel	+33-4-8111-35 33
		Address record changed: 2023-12-04

Basic data	Employees	n. a.
	Currency	EUR
	Annual sales	150,000,000 (fund size at closing (2014) 2014-01-01)

		* Document for »About Section«:

		Record changed: 2024-02-12

Picture Berlin Partner Top News Healthtech Company Mika 650x200px

More documents for ArchiMed (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)